title: [How dangerous is splenectomy in Hodgkin's disease? (author's transl)].
abstract: Serious complications aetiologically connected with the operation were found in 8 out of 51 patients (19 females, 32 males) who had undergone splenectomy for Hodgkin's disease. Weighing potential complications against the expected beneficial effects, clear indications for splenectomy are only found in stages I and IIa. In all more progressed clinical stages splenectomy should only be performed when 1) platelet deficiency existed prior to treatment, 2) additional irradiation of the splenic area is to be avoided, 3) oophoropexy is to be performed at the same time. When discussing the indication for splenectomy one should remember that a delay of treatment by approximately three weeks will result.
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D013156:Splenectomy / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000150:complications
vernacular_title: Wie gefährlich ist die Splenektomie bei Morbus Hodgkin?